期刊文献+

两种预处理方案在自体造血干细胞移植治疗自身免疫性疾病中的前瞻随机性研究 被引量:2

A prospective and randomized study of two conditioning regimens in treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation
原文传递
导出
摘要 目的探讨含/不含全身照射(TBI)作为预处理方案在自体外周血干细胞移植(APBSCT)治疗自身免疫性疾病中的造血重建、免疫重建、疗效和并发症等方面的差异。方法自1999—2006年6月,共有32例严重的自身免疫性疾病患者接受了 APBSCT。其中女性27例、男性5例,中位年龄29岁(15~49岁)。所有患者均采用环磷酰胺(CTX)+粒细胞集落刺激因子(rhG-CSF)方案动员,采集物均应用 CliniMACS 细胞分选仪分选 CD34^+细胞。21例患者预处理方案采用CTX+TBI,11例采用 CTX+抗胸腺细胞球蛋白(ATG)。结果两组的造血重建 CTX+TBI 组粒细胞植入中位时间为11 d,CTX+ATG 组为9 d,组间比较差异有统计学意义(P=0.003),两组血小板植入的中位时间分别为13 d 和8 d,组间比较,P=0.001;移植后12个月时两组患者淋巴细胞各亚群均已恢复,但 CD4/CD8比值仍倒置,各亚群水平两组间差异均无统计学意义;所有患者随访12个月以上,CTX+TBI 组有3例(14.3%)复发,CTX+ATG 组有2例(18.2%)复发,其余患者病情稳定;移植期间 CTX+TBI 组细菌感染发生率为5/21(23.8%),病毒感染1例(4.8%),放射性腮腺炎4/21(19%),CTX+ATG 组细菌感染发生率为2/11(18.2%),病毒感染2例(18.2%),血清病反应3/12(25%)。两组患者感染均在抗生素或抗病毒治疗后很快得到控制,均无因血小板减少引起致命的出血并发症。两组患者在随访时间内均未出现肺间质纤维化、白内障等远期并发症。结论含 TBI 的预处理方案在造血重建上迟于不含 TBI 的方案,但 CTX+TBI 的耐受性好,疗效上两者无明显差异,在免疫重建方面差别不明显。 Objective To investigate the differences in immune reconstitution, hematopoietic reeonstitution, efficacy, and complication between the two conditioning regimens with or without total body irradiation (TBI) in patients with refractory and severe autoimmune diseases (AID) who receiving autologous peripheral blood stem cell transplantation (APBSCT). Methods Thirty-two AID patients, 5 males and 27 females, aged 29 (15-49), underwent APBSCT. The CD34^+ cells were mobilized with eytoxan (CTX) + granulocyte-colony stimulating factor (G-CSF) and selected by clinical magnetic activated cell sorting (CliniMACS). The conditioning regimen included CTX + antithymocyte globulin (ATG) in 11 patients and CTX +TBI in 21 patients. All the patients were followed up for more than 12 months. Results The median time of granulocyte recovery were 11 and 9 days in the CTX + TB! and CTX + ATG groups respectively (P = 0. 003 ), the median time of platelet recovery were 13 and 8 days respectively ( P = 0. 001 ). In both groups, the lymphocyte subsets were recovered with the inverted CD4/CD8 ratio 12 months after transplantation. Relapse was seen in 3 cases of the CTX + TBI group ( 14.3% ), and 2 cases of the CTX + ATG group (18.2%) ,and the rest of patients remained free of AID. During transplantation incidence of bacteria infection occurred in 5 of the 21 cases in the CTX + TBI group (23.8%) and in 2 of the 11 cases of the CTX + ATG group ( 18.2% ) respectively; viral infection occurred in 1 of the 21 cases of the CTX + TBI group (4.8%) and in 2 of the 11 cases of the CTX + ATG group ( 18.2% ) respectively. The number of radiated parotitis was 4 among the 21 patients of the CTX + TBI group( 19% )and was 3 among the 12 patients of the CTX + ATG group(25% ). Serum sickness reaction occurred in 3 of the 12 patients of the CTX + ATG group ( 25% ). Bacterial and viral infections were cured soon after antibacterial or antiviral therapy, no fatal bleeding occurred due to thrombocytopenia in both groups. Conduslon The conditioning regimen of TBI + CTX delays the hematopoietic reconstitution compared with the ATG + CTX regimen in treating AID. The regimen of CTX + TBI can be better tolerated, but there are no significant differences in efficacy and immune reconstitution among these two regimens.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第24期1689-1692,共4页 National Medical Journal of China
关键词 造血干细胞移植 移植 自体 移植预处理 自身免疫疾病 Hematopoietic stem cell transplantation Transplantation, autologous Transplantation conditioning Autoimmune diseases
  • 相关文献

参考文献13

  • 1Hough RE, Snowden JA, Wulfraat NM, et al. Haemopeietic stem cell transplantation in autoimmune disease : a European perspective. Br J Haematol, 2004, 128:432-459.
  • 2赵岩,周道斌,冷晓梅,王书杰,李太生,段云,沈悌,赵永强,张洁萍,白连钧,崔巍,张福全,曾小峰,张奉春,董怡,唐福林.自体外周血干细胞移植治疗系统性自身免疫病[J].中华医学杂志,2004,84(24):2077-2081. 被引量:17
  • 3周道斌,赵岩,赵丽丹,冷晓梅,张洁萍,汪玄,沈悌.严重自身免疫性疾病患者的外周血CD34^+细胞动员[J].基础医学与临床,2006,26(4):405-408. 被引量:3
  • 4Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood, 1998,92 : 1471-1490.
  • 5Tyndall A, Passweg J, Gratwohl A. Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000. Ann Rheum Dis, 2001,60:702-707.
  • 6Fassas A, Anagnostopoulos A, Kazis A, et al. Autologous stem cell transplantation in progrssive mutiple sclerosis an interim analysis of efficacy. J Clin Immunol, 2000,20:24-30.
  • 7Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism(EULAR) and the European Group for Blood and Marrow Transplantation (EMBT). Bone Marrow Transplant, 1997,19:643-645.
  • 8Brodsky RA. High-dose cyclophosphamide for aplastic anemia and autoimmunity. Curr Opin Oncol,2002,14 : 143-146.
  • 9van Bekkum DW. Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation. Bone Marrow Transplant, 2000,25:357-364.
  • 10McSweeney PA, Nash RA, Sullivan KM, et al. High-dose immunosuppressive therapy for severe systemic sclerosis:initial outcomes. Blood ,2002,100 : 1602-1610.

二级参考文献17

  • 1Tyndall A, Grotwohl A. Immune ablation and stem-cell therapy in autoimmune disease clinical experience. Arthritis Res, 2000, 2: 276-280.
  • 2Bombradier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI, a disease activity index for lupus patients. Arthritis Rheum, 1992, 35: 630-640.
  • 3Flson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum, 1993, 36: 729-740.
  • 4Prevoo ML, Van′t Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum, 1995, 38: 44-48.
  • 5Leng XM, Zhao Y, Zhou DB, et al. Study of treatment of refractory rheumatoid arthritis with autologous peripheral blood stem cell transplantation. Natl Med J China, 2002, 82: 748-751.冷晓梅,赵岩,周道斌,等. 自体外周血干细
  • 6Adachi Y, Inaba M, Amoh Y, et al. Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice. Immunobiology, 1995, 192: 218-230.
  • 7Verburg RJ, Kruize AA, van den Hoogen FH, et al. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis. Arthritis Rheum, 2001, 44: 754-760.
  • 8van Laar JM. Immune ablation and stem cell therapy in autoimmune disease: immunological reconstitution after high-dose immunosuppression and hematopoietic stem cell transplantation. Arthritis Res, 2000, 2: 270-275.
  • 9Pavletic SZ, Odell JR, Pirruccello SJ, et al. Intensive immunoablation and autologous blood cell transplantation in patients with refracrtory rheumatoid arthritis: the University of Nebraska experience. J Rheumatol, 2001, 28 (Suppl 64):13-20.
  • 10Bingham SJ, Snowden J, McGonagle D, et al. Autologous stem cell transplantation for rheumatoid arthritis-interim report of 6 patients. J Rheumatol, 2001, 28(Suppl 64): 21-24.

共引文献16

同被引文献25

  • 1中华医学会糖尿病学分会.中华医学会糖尿病学分会关于干细胞移植治疗糖尿病的立场声明[J].中华糖尿病杂志,2010,2(6). 被引量:36
  • 2赵岩,周道斌,冷晓梅,王书杰,李太生,段云,沈悌,赵永强,张洁萍,白连钧,崔巍,张福全,曾小峰,张奉春,董怡,唐福林.自体外周血干细胞移植治疗系统性自身免疫病[J].中华医学杂志,2004,84(24):2077-2081. 被引量:17
  • 3张铁梅.糖尿病发病机制//迟家敏.实用糖尿病学.3版.北京:人民卫生出版社,2009:17.
  • 4Nikolic B, Takeuchi Y, Leykin I, et al. Mixed hematopoietic cbimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes, 2004,53 : 376- 383.
  • 5Voltarelli JC, Couri CE, Straeieri AB, et al. Autologous nonmyeloablative hematopoietie stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA,2007,297:1568-1576.
  • 6American Diabetes Association. Diagnosis and classification of diabetes. Diabetes Care,2008,31 Suppl 1 : S55-S60.
  • 7Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant, 2005, 35: 869-879.
  • 8Annaloro C, Onida F, Lambertenghi Deliliers G. Autologous hematopoietic stem cell transplantation in autoimmune diseases. Expert Rev Hematol,2009 ,2 :699-715.
  • 9Knip M, Veijola R, Virtanen SM, et al. Environmental triggers and determinants of type 1 diabetes [ J ] . Diabetes, 2005,54 ( Suppl 2 ): S125-S136.
  • 10张铁梅.糖尿病发病机制[M].北京:人民卫生出版社,2009:17.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部